New Zealand markets open in 2 hours 50 minutes

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
54.01-1.37 (-2.47%)
At close: 04:00PM EDT
54.01 0.00 (0.00%)
After hours: 07:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close55.38
Open55.50
Bid53.94 x 200
Ask54.03 x 400
Day's range53.35 - 55.69
52-week range37.55 - 91.10
Volume1,313,469
Avg. volume1,344,549
Market cap4.586B
Beta (5Y monthly)1.77
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    CRISPR Therapeutics to Participate in Upcoming Investor Conferences

    ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June. Jefferies Healthcare ConferenceDate: Wednesday, June 5, 2024Time: 10:00 a.m. ET Goldman Sach’s 45th Annual Global Healthcare ConferenceDate: Tuesday, June 11, 20

  • GlobeNewswire

    CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

    -Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024. Dr. Patel is an experienced drug developer who has worked across a wid

  • GlobeNewswire

    CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

    ZUG, Switzerland and BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the Bank of America Securities Health Care Conference on Wednesday, May 15, 2024, at 12:20 p.m. ET. A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of th